company
as of 2026-07-01Hannover Medical School
at a glance
4 trials sponsored · 60 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
60 assets
AmisulprideAripiprazoleClozapineFlupentixolFluphenazineHaloperidolOlanzapinePaliperidonePerphenazineQuetiapineRisperidoneSulpirideZiprasidoneZuclopenthixolAcamprosateAlprazolamAmitriptylineAmitriptyline oxideBenperidolBiperidenBromazepamBrotizolamBupropionBuspironeCarbamazepineChloral HydrateChlorprothixeneCitalopramClobazamClomethiazoleClomipramineClonazepamDiazepamDiphenhydramineDonepezilDoxepinDuloxetineFlurazepamFluspirileneFluvoxamineGabapentinGalantamineHydroxyzineImipramineIntermittent theta-burst stimulationLacosamideLevetiracetamLevomepromazineLithiumLorazepamLormetazepamMaprotilineMelatoninMelperoneMemantineMianserinMidazolamMoclobemideNicergolineNortriptyline
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Amisulpride
drugsmall molecule
Aripiprazole
drugsmall molecule
Clozapine
drugsmall molecule
Flupentixol
drugsmall molecule
Fluphenazine
drugsmall molecule
Haloperidol
drugsmall molecule
Olanzapine
drugsmall molecule
Paliperidone
drugsmall molecule